NCT06098092

Brief Summary

The aim of the study is to perform an experimental validation of the long-term accuracy of blood pressure measurement using the Samsung Galaxy Smartwatch

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable hypertension

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

October 13, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

October 9, 2023

Last Update Submit

March 10, 2026

Conditions

Keywords

SmartwatchBlood pressureHeart rate

Outcome Measures

Primary Outcomes (1)

  • Blood pressure agreement between smartwatch and digital tonometer

    The agreement of Blood pressure measurements between smartwatch and medical grade reference digital tonometer

    20-40 days

Secondary Outcomes (1)

  • Heart rate agreement between smartwatch and digital tonometer

    20-40 days

Study Arms (1)

Long-term Blood pressure and Heart rate monitoring with reference digital tonometer and smartwatch

EXPERIMENTAL

Measurement of a non-invasive Blood pressure and Heart rate using a reference medical grade digital tonometer Omron and a smartwatch Samsung Galaxy Watch during 20-40 days every morning and evening.

Other: Long-term non-invasive Blood pressure monitoring

Interventions

All measurements during the experiment include only non-invasive Blood pressure and Heart rate measurements. Measurements will be taken using a smartwatch attached to the wrist and a digital tonometer with a cuff placed on the other arm. Paired readings will be compared.

Also known as: Long-term non-invasive Heart rate monitoring
Long-term Blood pressure and Heart rate monitoring with reference digital tonometer and smartwatch

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteer

You may not qualify if:

  • post-traumatic conditions of the upper limbs
  • tattoos, birthmarks, injuries or diseases of the skin on the wrists of hands
  • cardiac arrhythmias
  • circulatory or peripheral varcular disease
  • aortic valve disease
  • myocardiopathy
  • other cardiovascular diseases
  • pregnancy
  • kidney disease
  • diabetes
  • neurotic disorder
  • haemostatic disorders
  • use of blood-thinning drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Czech Technical University in Prague

Kladno, 27201, Czechia

Location

Faculty of biomedical Engineering, Czech Technical University in Prague

Kladno, 27201, Czechia

Location

Related Publications (1)

  • Walzel S, Sebestova H, Rafl-Huttova V, Rozanek M, Rafl J. Long-term accuracy and stability of blood pressure measurements from a smartwatch: Prospective validation study. Digit Health. 2026 Jan 22;12:20552076261415923. doi: 10.1177/20552076261415923. eCollection 2026 Jan-Dec.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Jakub Rafl

    Czech Technical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Interventional prospective single-arm study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2023

First Posted

October 24, 2023

Study Start

October 13, 2023

Primary Completion

October 30, 2025

Study Completion

November 1, 2025

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

The measured data will be shared publicly in the data repository on web page: https://ventilation.fbmi.cvut.cz/data/

Time Frame
Unlimited from the time of processing complete measured data
Access Criteria
Publicly available to everyone
More information

Locations